Literature DB >> 9752721

Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.

A G Zimmermann1, J J Gu, J Laliberté, B S Mitchell.   

Abstract

Guanine nucleotide synthesis is essential for the maintenance of normal cell growth and function, as well as for cellular transformation and immune responses. The expression of two genes encoding human inosine-5'-monophosphate dehyrogenase (IMPDH) type I and type II results in the translation of catalytically indistinguishable enzymes that control the rate-limiting step in the de novo synthesis of guanine nucleotides. Cellular IMPDH activity is increased more than 10-fold in activated peripheral blood T lymphocytes and is attributable to the increased expression of both the type I and type II enzymes. In contrast, abrogation of cellular IMPDH activity by selective inhibitors prevents T lymphocyte activation and establishes a requirement for elevated IMPDH activity in T lymphocytic responses. In order to assess the molecular mechanisms governing the expression of the IMPDH type I and type II genes in resting and activated peripheral blood T lymphocytes, we have cloned the human IMPDH type I and type II genes and characterized their genomic organization and their respective 5'-flanking regions. Both genes contain 14 highly conserved exons that vary in size from 49 to 207 base pairs. However, the intron structures are completely divergent, resulting in disparities in gene length (18 kilobases for type I and 5.8 kilobases for type II). In addition, the 5'-regulatory sequences are highly divergent; expression of the IMPDH type I gene is controlled by three distinct promoters in a tissue specific manner while the type II gene is regulated by a single promoter and closely flanked in the 5' region by a gene of unknown function. The conservation of the IMPDH type I and type II coding sequence in the presence of highly divergent 5'-regulatory sequences points to a multifactorial control of enzyme expression and suggests that tissue-specific and/or developmentally specific regulation of expression may be important. Delineation of these regulatory mechanisms will aid in the elucidation of the signaling events that ultimately lead to the synthesis of guanine nucleotides required for cellular entry into S phase and the initiation of DNA replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9752721     DOI: 10.1016/s0079-6603(08)60827-2

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


  27 in total

1.  Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.

Authors:  R J Shaw; J L Wilson; K T Smith; D Reines
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

2.  Transcription initiation of the yeast IMD2 gene is abolished in response to nutrient limitation through a sequence in its coding region.

Authors:  Mafalda Escobar-Henriques; Martine A Collart; Bertrand Daignan-Fornier
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 3.  Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.

Authors:  Murtaza S Nagree; Lucía López-Vásquez; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

Review 4.  Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.

Authors:  Gerson Dierley Keppeke; S John Calise; Edward K L Chan; Luis Eduardo C Andrade
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 5.  Dynamic reorganization of metabolic enzymes into intracellular bodies.

Authors:  Jeremy D O'Connell; Alice Zhao; Andrew D Ellington; Edward M Marcotte
Journal:  Annu Rev Cell Dev Biol       Date:  2012       Impact factor: 13.827

6.  Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.

Authors:  Li-Xi Liao; Xiao-Min Song; Li-Chao Wang; Hai-Ning Lv; Jin-Feng Chen; Dan Liu; Ge Fu; Ming-Bo Zhao; Yong Jiang; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

7.  Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene.

Authors:  Petra Kozma; Dianna K Hughbanks-Wheaton; Kirsten G Locke; Garry E Fish; Anisa I Gire; Catherine J Spellicy; Lori S Sullivan; Sara J Bowne; Stephen P Daiger; David G Birch
Journal:  Am J Ophthalmol       Date:  2005-10-07       Impact factor: 5.258

8.  Analysis of the interaction between piD261/Bud32, an evolutionarily conserved protein kinase of Saccharomyces cerevisiae, and the Grx4 glutaredoxin.

Authors:  Raffaele Lopreiato; Sonia Facchin; Geppo Sartori; Giorgio Arrigoni; Stefano Casonato; Maria Ruzzene; Lorenzo A Pinna; Giovanna Carignani
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

9.  Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo.

Authors:  Christine C McPhillips; Judith W Hyle; Daniel Reines
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

10.  The critical cis-acting element required for IMD2 feedback regulation by GDP is a TATA box located 202 nucleotides upstream of the transcription start site.

Authors:  Mafalda Escobar-Henriques; Bertrand Daignan-Fornier; Martine A Collart
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.